Storgate LLC Takes Position in Willis Towers Watson Public Limited Company $WTW

Storgate LLC purchased a new stake in shares of Willis Towers Watson Public Limited Company (NASDAQ:WTW) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 2,179 shares of the company’s stock, valued at approximately $716,000.

A number of other hedge funds have also recently made changes to their positions in WTW. Brighton Jones LLC grew its position in shares of Willis Towers Watson Public by 4.7% during the 4th quarter. Brighton Jones LLC now owns 1,368 shares of the company’s stock valued at $429,000 after purchasing an additional 61 shares in the last quarter. NewEdge Advisors LLC grew its position in shares of Willis Towers Watson Public by 7.6% during the 1st quarter. NewEdge Advisors LLC now owns 2,588 shares of the company’s stock valued at $875,000 after purchasing an additional 182 shares in the last quarter. Empowered Funds LLC grew its position in shares of Willis Towers Watson Public by 16.9% during the 1st quarter. Empowered Funds LLC now owns 2,400 shares of the company’s stock valued at $811,000 after purchasing an additional 347 shares in the last quarter. Geneos Wealth Management Inc. grew its position in shares of Willis Towers Watson Public by 38.6% during the 1st quarter. Geneos Wealth Management Inc. now owns 140 shares of the company’s stock valued at $47,000 after purchasing an additional 39 shares in the last quarter. Finally, First Trust Advisors LP grew its position in shares of Willis Towers Watson Public by 12.6% during the 2nd quarter. First Trust Advisors LP now owns 14,806 shares of the company’s stock valued at $4,538,000 after purchasing an additional 1,659 shares in the last quarter. 93.09% of the stock is currently owned by hedge funds and other institutional investors.

Willis Towers Watson Public Stock Up 0.7%

Shares of NASDAQ:WTW opened at $262.63 on Friday. Willis Towers Watson Public Limited Company has a 52-week low of $240.61 and a 52-week high of $352.79. The firm has a fifty day moving average of $269.49 and a 200 day moving average of $297.53. The firm has a market capitalization of $24.81 billion, a PE ratio of 15.31, a price-to-earnings-growth ratio of 0.84 and a beta of 0.43. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.92 and a current ratio of 2.92.

Willis Towers Watson Public (NASDAQ:WTW) last announced its earnings results on Friday, May 1st. The company reported $3.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.65 by $0.07. Willis Towers Watson Public had a net margin of 16.84% and a return on equity of 21.52%. The company had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the business earned $3.13 earnings per share. The firm’s quarterly revenue was up 8.5% compared to the same quarter last year. As a group, research analysts anticipate that Willis Towers Watson Public Limited Company will post 19.53 EPS for the current fiscal year.

Willis Towers Watson Public Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a yield of 1.5%. The ex-dividend date is Tuesday, June 30th. Willis Towers Watson Public’s dividend payout ratio is presently 22.39%.

Insider Transactions at Willis Towers Watson Public

In other Willis Towers Watson Public news, insider Lucy Clarke purchased 1,896 shares of the business’s stock in a transaction on Wednesday, May 6th. The stock was acquired at an average cost of $263.37 per share, for a total transaction of $499,349.52. Following the completion of the transaction, the insider directly owned 22,717 shares in the company, valued at approximately $5,982,976.29. This represents a 9.11% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on WTW. Cantor Fitzgerald reduced their price target on shares of Willis Towers Watson Public from $363.00 to $354.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Morgan Stanley cut their target price on shares of Willis Towers Watson Public from $330.00 to $320.00 and set an “equal weight” rating for the company in a research report on Monday, April 6th. UBS Group cut their target price on shares of Willis Towers Watson Public from $400.00 to $374.00 and set a “buy” rating for the company in a research report on Tuesday. Keefe, Bruyette & Woods cut their target price on shares of Willis Towers Watson Public from $384.00 to $380.00 and set an “outperform” rating for the company in a research report on Tuesday, May 12th. Finally, Piper Sandler cut their target price on shares of Willis Towers Watson Public from $341.00 to $283.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $350.00.

Willis Towers Watson Public Company Profile

Willis Towers Watson Public (NASDAQ: WTW) is a global advisory, broking and solutions company that helps organizations manage risk, optimize benefits and cultivate talent. The firm combines insurance brokerage and risk management capabilities with human capital and benefits consulting, actuarial and analytics services, and technology-enabled solutions. Willis Towers Watson serves a broad client base that includes multinational and mid-sized corporations, public sector organizations, insurers and investment managers.

The company’s core activities encompass commercial and reinsurance brokerage, risk transfer and risk-financing advice, and claims advocacy, alongside employee benefits and retirement consulting.